Sei Investments Co. Buys 12,142 Shares of Humana Inc. (NYSE:HUM)

Sei Investments Co. lifted its stake in Humana Inc. (NYSE:HUM) by 16.3% during the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 86,472 shares of the insurance provider’s stock after acquiring an additional 12,142 shares during the period. Sei Investments Co. owned 0.07% of Humana worth $21,937,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the stock. American Century Companies Inc. raised its position in shares of Humana by 8.8% in the fourth quarter. American Century Companies Inc. now owns 12,655 shares of the insurance provider’s stock valued at $3,211,000 after purchasing an additional 1,027 shares during the period. Mizuho Securities USA LLC lifted its position in Humana by 46.2% during the 4th quarter. Mizuho Securities USA LLC now owns 11,412 shares of the insurance provider’s stock worth $2,895,000 after acquiring an additional 3,605 shares during the last quarter. Virtu Financial LLC boosted its holdings in Humana by 85.6% during the fourth quarter. Virtu Financial LLC now owns 3,699 shares of the insurance provider’s stock valued at $938,000 after acquiring an additional 1,706 shares during the period. Sector Gamma AS increased its stake in shares of Humana by 16.7% in the fourth quarter. Sector Gamma AS now owns 14,000 shares of the insurance provider’s stock worth $3,552,000 after purchasing an additional 2,000 shares during the period. Finally, TD Private Client Wealth LLC lifted its position in shares of Humana by 16.3% during the 4th quarter. TD Private Client Wealth LLC now owns 2,464 shares of the insurance provider’s stock worth $625,000 after purchasing an additional 346 shares during the last quarter. 92.38% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

A number of research firms have issued reports on HUM. JPMorgan Chase & Co. dropped their price target on Humana from $257.00 to $256.00 and set a “neutral” rating on the stock in a research report on Tuesday, February 18th. Truist Financial increased their price target on shares of Humana from $260.00 to $290.00 and gave the company a “hold” rating in a report on Monday, January 6th. StockNews.com lowered shares of Humana from a “buy” rating to a “hold” rating in a research report on Tuesday, March 18th. Royal Bank of Canada reissued an “outperform” rating and set a $283.00 target price on shares of Humana in a research report on Wednesday, February 12th. Finally, Morgan Stanley cut their price target on Humana from $301.00 to $285.00 and set an “equal weight” rating for the company in a report on Wednesday, February 12th. Eighteen research analysts have rated the stock with a hold rating and five have given a buy rating to the stock. According to MarketBeat, the company presently has a consensus rating of “Hold” and an average price target of $285.68.

Insiders Place Their Bets

In other Humana news, insider Timothy S. Huval sold 3,703 shares of the company’s stock in a transaction on Tuesday, December 31st. The stock was sold at an average price of $256.26, for a total transaction of $948,930.78. Following the transaction, the insider now owns 8,181 shares of the company’s stock, valued at approximately $2,096,463.06. This represents a 31.16 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Insiders own 0.37% of the company’s stock.

Humana Stock Performance

NYSE HUM opened at $270.27 on Thursday. Humana Inc. has a 1-year low of $213.31 and a 1-year high of $406.46. The company has a 50 day moving average of $270.63 and a 200-day moving average of $274.97. The company has a current ratio of 1.76, a quick ratio of 1.76 and a debt-to-equity ratio of 0.68. The firm has a market cap of $32.62 billion, a price-to-earnings ratio of 27.16, a PEG ratio of 2.05 and a beta of 0.57.

Humana (NYSE:HUM) last released its quarterly earnings results on Tuesday, February 11th. The insurance provider reported ($2.16) earnings per share for the quarter, beating analysts’ consensus estimates of ($2.26) by $0.10. Humana had a return on equity of 11.70% and a net margin of 1.02%. On average, equities analysts forecast that Humana Inc. will post 16.47 earnings per share for the current fiscal year.

Humana Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, April 25th. Investors of record on Friday, March 28th will be given a dividend of $0.885 per share. The ex-dividend date is Friday, March 28th. This represents a $3.54 annualized dividend and a yield of 1.31%. Humana’s dividend payout ratio (DPR) is 35.58%.

Humana Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.